PCNA and neoplasm: Treatment of mice with both μ-21-ON and μ-21-ON/μ-17-ON/μ-155-ON led to an almost 2-fold decrease in the number of PCNA-positive tumor cells compared with the control groups, being equal to 35% of PCNA-positive cells (Figure 7c,e).